Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) recurrence after liver transplantation occurs in approximately 20% of patients. Most of these patients use immunosuppressant drugs. Meanwhile, patients with HCC recurrence are frequently treated with the small molecule kinase inhibitor (SMKI) sorafenib. However, sorafe...
Saved in:
Main Authors: | Koen G. A. M. Hussaarts (Author), Leni van Doorn (Author), Sander Bins (Author), Dave Sprengers (Author), Peter de Bruijn (Author), Roelof W. F. van Leeuwen (Author), Stijn L. W. Koolen (Author), Teun van Gelder (Author), Ron H. J. Mathijssen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
by: Koen G. A. M. Hussaarts, et al.
Published: (2020) -
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients
by: Leni van Doorn, et al.
Published: (2021) -
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
by: Ruben A. G. van Eerden, et al.
Published: (2021) -
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors
by: Ruben A. G. van Eerden, et al.
Published: (2021) -
A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients
by: Kim L. W. Bunthof, et al.
Published: (2022)